Advances in the Management of Heart Failure ( VI ) Cardiac Resynchronization for Heart Failure : Background , Methods , Indications , and Results

98 Heart failure is one of the most prevalent diseases in industrialized countries. Although the prognosis of patients with heart failure is still poor, in recent decades new therapies have been investigated in order to improve quality of life and survival. However, up to 30% of the patients with advanced heart failure present disturbances in intraventricular conduction, and this produces asynchrony of ventricular contractility, leading to further deterioration in heart function. Cardiac resynchronization therapy can improve the synchrony of ventricular contractility. Numerous studies have demonstrated the benefits of biventricular stimulation therapy for improving hemodynamic parameters, quality of life, 6-minute walking test performance and functional class in patients with heart failure, ventricular systolic dysfunction and disturbances in intraventricular conduction. Some studies have demonstrated longer survival times in patients treated with cardiac resynchronization plus a defibrillator. Nonetheless, many questions about the benefits of heart resynchronization therapy, site of stimulation and best type of device (pacemaker or defibrillator) remain unresolved.

[1]  J. M. Moya Mur,et al.  [Cardiac resynchronization for heart failure: background, methods, indications and results]. , 2004, Revista espanola de cardiologia.

[2]  F. García-Cosío,et al.  «Resincronización ventricular» en la insuficiencia cardíaca: ¿un método bien establecido o una línea de progreso con muchos interrogantes? , 2003 .

[3]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[4]  Jeffrey A Feinstein,et al.  Electrical Resynchronization: A Novel Therapy for the Failing Right Ventricle , 2003, Circulation.

[5]  S. Goodman,et al.  Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. , 2003, JAMA.

[6]  J. Sanderson,et al.  Fragile left atrial thrombus successfully treated with anticoagulants , 2003, Heart.

[7]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[8]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[9]  Peter Søgaard,et al.  Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. , 2002, Journal of the American College of Cardiology.

[10]  P. McCullough,et al.  Congestive heart failure and QRS duration: establishing prognosis study. , 2002, Chest.

[11]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[12]  Jiang Ding,et al.  Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. , 2002, Journal of the American College of Cardiology.

[13]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[14]  H. Krumholz,et al.  Spectrum of heart failure in older patients: results from the National Heart Failure project. , 2002, American heart journal.

[15]  Massimo Santini,et al.  Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. , 2002, Journal of the American College of Cardiology.

[16]  D. Kass,et al.  Retiming the failing heart: principles and current clinical status of cardiac resynchronization. , 2002, Journal of the American College of Cardiology.

[17]  P. Brunel,et al.  Optimal Stimulation of the Left Ventricle , 2002, Journal of cardiovascular electrophysiology.

[18]  J. Brugada,et al.  Inappropriate Tachycardia Detection by a Biventricular Implantable Cardioverter Defibrillator , 2002, Pacing and clinical electrophysiology : PACE.

[19]  Thomas Lavergne,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay , 2001 .

[20]  J. Cleland,et al.  Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK‐CD, CHRISTMAS, OPTIME‐CHF , 2001, European journal of heart failure.

[21]  Gregory S. Nelson,et al.  Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block , 2000, Circulation.

[22]  W. Abraham,et al.  Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). , 2000, Journal of cardiac failure.

[23]  A. Feldman,et al.  Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. , 2000, Journal of cardiac failure.

[24]  N. Patel,et al.  How many people with heart failure are appropriate for biventricular resynchronization? , 2000, European heart journal.

[25]  M. Gold,et al.  Atrial defibrillation with a transvenous lead: a randomized comparison of active can shocking pathways. , 1999, Journal of the American College of Cardiology.

[26]  Andrew P. Kramer,et al.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. , 1999, Circulation.

[27]  L. Padeletti,et al.  Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. , 1999, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  A. Auricchio,et al.  Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. , 1999, The American journal of cardiology.

[29]  E. Daoud,et al.  Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. , 1999, The American journal of cardiology.

[30]  V. Fuster,et al.  Epidemic of cardiovascular disease and stroke: the three main challenges. Presented at the 71st scientific sessions of the American Heart Association. Dallas, Texas. , 1999, Circulation.

[31]  J. McMurray,et al.  Clinical epidemiology of heart failure: public and private health burden. , 1998, European heart journal.

[32]  H Le Breton,et al.  Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. , 1998, Journal of the American College of Cardiology.

[33]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[34]  J. Blanc,et al.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.

[35]  M R Gold,et al.  Lead system optimization for transvenous defibrillation. , 1997, The American journal of cardiology.

[36]  F. Rodríguez‐Artalejo,et al.  Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. , 1997, European heart journal.

[37]  A. Lazarus,et al.  Multisite Pacing for End‐Stage Heart Failure: Early Experience , 1996, Pacing and clinical electrophysiology : PACE.

[38]  M. Fisher,et al.  Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. , 1995, Journal of the American College of Cardiology.

[39]  M. Rosenqvist,et al.  Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. , 1995, The American journal of cardiology.

[40]  S. Yusuf,et al.  Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. , 1993, Journal of the American College of Cardiology.

[41]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[42]  D. Andresen,et al.  First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[43]  P E Leaverton,et al.  Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.

[44]  C. Ng,et al.  Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. , 1990, The American journal of cardiology.

[45]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[46]  A. Friedl,et al.  [Pacing therapies for congestive heart failure considering the results of the PATH-CHF study]. , 2001, Zeitschrift fur Kardiologie.

[47]  A. Raviele,et al.  The InSync Italian Registry : analysis of clinical outcome and considerations on the selection of candidates to left ventricular resynchronization , 2000 .

[48]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1997, Circulation.

[49]  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1987, The New England journal of medicine.

[50]  Javier Alzueta,et al.  An Even More Physiological Pacing: Changing the Sequence of Ventricular Activation , 1983 .